Login / Signup

Reflector-Guided Localisation of Non-Palpable Breast Lesions: A Prospective Evaluation of the SAVI SCOUT® System.

Umar WazirIham KasemMichael J MichellTamara SuarisDavid EvansAnmol MalhotraKefah Mokbel
Published in: Cancers (2021)
Wire-guided localisation (WGL) has been the mainstay for localising non-palpable breast lesions before excision. Due to its limitations, various wireless alternatives have been developed. In this prospective study, we evaluate the role of radiation-free wireless localisation using the SAVI SCOUT® system at the London Breast Institute. A total of 72 reflectors were deployed in 67 consecutive patients undergoing breast conserving surgery for non-palpable breast lesions. The mean interval between deployment and surgery for the therapeutic cases was 18.8 days (range: 0-210). The median deployment duration was 5 min (range: 1-15 min). The mean distance from the lesion was 1.1 mm (median distance: 0; range: 0-20 mm). The rate of surgical localisation and retrieval of the reflector was 98.6% and 100%, respectively. The median operating time was 28 min (range: 15-55 min) for the therapeutic excision of malignancy and 17 min (range: 15-24) for diagnostic excision. The incidence of reflector migration was 0%. Radial margin positivity in malignant cases was 7%. The median weight for malignant lesions was 19.6 g (range: 3.5-70 g). Radiologists and surgeons rated the system higher than WGL (93.7% and 98.6%, respectively; 60/64 and 70/71). The patient mean satisfaction score was 9.7/10 (n = 47, median = 10; range: 7-10). One instance of signal failure was reported. In patients who had breast MRI after the deployment of the reflector, the MRI void signal was <5 mm (n = 6). There was no specific technique-related surgical complication. Our study demonstrates that wire-free localisation using SAVI SCOUT® is an effective and time-efficient alternative to WGL with excellent physician and patient acceptance.
Keyphrases
  • patients undergoing
  • minimally invasive
  • emergency department
  • coronary artery bypass
  • computed tomography
  • neoadjuvant chemotherapy
  • coronary artery disease
  • acute coronary syndrome
  • atrial fibrillation